The recommendations listed in the present guideline are, whenever possible, evidence
based. An initial extensive evidence review, which included literature derived from research …

Introduction Previous research has shown that statin adherence for the primary prevention of
CVD is lower compared to secondary prevention populations. Therefore the aim of this …

Background Poor adherence may have a major impact on clinical outcome, contributing to
substantial worsening of disease, increased health care costs and even death. With …

Although medication adherence is commonly measured in electronic datasets using the
proportion of days covered (PDC), no standardized approach is used to calculate and report …

BACKGROUND: Widespread use of statins has improved hypercholesterolemia
management, yet a significant proportion of patients remain at risk for cardiovascular (CV) …

Aim: Analyze the relative risks of critical cardiovascular outcomes and mortality associated
with adherence to statin treatment in a clinical setting in people with no history of prior …

Background Life course gender-role traits and social stereotypes could affect the pattern of
medication adherence in old age. Objectives The main purpose of this study was to …

Background Maintaining adherence to statins reduces the risk of an initial cardiovascular
disease (CVD) event in high-risk individuals (primary prevention) and additional CVD events …

Background Chronic diseases have a widespread impact on health outcomes and costs in
the United States. Heart disease and diabetes are among the biggest cost burdens on the …

Background It is important to achieve the low-density lipoprotein cholesterol (LDL-C) goal
recommended by clinical guidelines in managing the risk of cardiovascular (CV) events …